Results 211 to 220 of about 3,290,822 (384)

Risk of primary Sjogren's Syndrome following human papillomavirus infections: a nationwide population-based cohort study. [PDF]

Front Immunol, 2022
Chen HH, Ma KS, Dong C, Chang WJ, Gao KR, Perng WT, Huang JY, Wei JC.   +7 more
europepmc   +1 more source

Laboratory techniques in the investigation of human papillomavirus infection.

, 1992
E.-M. de Villiers
openalex   +1 more source

Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities

Journal of Clinical Microbiology, 2013
M. Schmitt, C. Depuydt, I. Benoy, J. Bogers, J. Antoine, M. Arbyn, M. Pawlita   +6 more
semanticscholar   +1 more source

Organoid Models to Study Human Infectious Diseases

Cell Proliferation, EarlyView.
Our manuscript reviews the role of organoids as models for studying human infectious diseases, highlighting their irreplaceable contributions to drug testing and vaccine development for significant infectious diseases including HIV, ZIKV, SARS‐CoV‐2 and MPXV.
Sijing Zhu, Dan Chen, Xinzhi Yang, Liuliu Yang, Yuling Han   +4 more
wiley   +1 more source

AHCC^® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections. [PDF]

Front Oncol, 2022
Smith JA, Gaikwad AA, Mathew L, Rech B, Faro JP, Lucci JA, Bai Y, Olsen RJ, Byrd TT.   +8 more
europepmc   +1 more source

Prognostic Factors in Cervical Human Papillomavirus Infections

, 1992
Vesa Kataja, S. SYRJANEN, R. MANTYJARVI, Merja Yliskoski, Seppo Saarikoski, Karí Syrjänen   +5 more
openalex   +1 more source

Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection [PDF]

, 2000
Lennart Kjellberg, G. Hallmans, A-M Åhren, Robert Johansson, F. Bergman, Göran Wadell, T Ångström, Joakim Dillner   +7 more
openalex   +1 more source

CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential

Cell Proliferation, EarlyView.
CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far, Marziyeh Akbari, Mohammad Amin Habibi, Morteza Katavand, Sherko Nasseri   +4 more
wiley   +1 more source

Human papillomavirus infections in low-grade squamous intraepithelial lesion in Peruvian pregnant woman: A cross-sectional cytology-based study. [PDF]

Health Sci Rep, 2022
Moya-Salazar J, Rojas-Zumaran V, Bravo L O, Moscoso G, Contreras-Pulache H.   +4 more
europepmc   +1 more source

Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident Infection [PDF]

, 2000
Joseph J. Carter, Laura A. Koutsky, James P. Hughes, Shu Kuang Lee, Jane Kuypers, Nancy B. Kiviat, Denise A. Galloway   +6 more
openalex   +1 more source